Aspirin in primary prevention of atherosclerosis: a skin of grief that keeps shrinking
Louis MONNIER, Clinical Research Institute, Montpellier Despite the significant advances represented by the use of high-potency statins and new antiplatelet or antithrombotic treatments, low-dose aspirin remains an effective treatment in the secondary prevention of cardiovascular diseases and events (reduction of the relative risk of order of 20%). On the other hand, the prescription of aspirin … Read more